-
The University of Bristol Selects Signant Health’s TrialConsent® to Assess the Impact and Value of eConsent in an Oncology Trial
Oct 14, 2019, 09:12 AM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Oct 14, 2019 - The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) at the University of Bristol has selected Signant Health, formerly CRF Health and Bracket, as its partner to provide electronic informed consent (eConsent) support for an oncology trialFull story -
New AI Model Predicts Clinical Translation Of Biomedical Research
Oct 11, 2019, 07:50 AM by Michael CroftFull storyBio-IT World | The US National Institutes of Health's Office of Portfolio Analysis has developed a machine learning model that predicts whether a scientific advance is likely to translate to the clinic.
-
Alfa Chemistry Announced to offer Surfactant Products
Oct 10, 2019, 23:52 PM by Michael CroftNEW YORK, NY - Oct 1, 2019 - On September 25, 2019, Alfa Chemistry, a well known New York-based chemical supplier, announced to enlarge its product lines by offering a wide range of surfactant products to their customersFull story -
Physician Support Organization Health Plus Management Announces Appointments for Two Key Leadership Positions
Oct 10, 2019, 12:23 PM by Michael CroftUNIONDALE, NY, NY, UNITED STATES - Oct 10, 2019 - UNIONDALE, N.Y.--(BUSINESS WIRE)--Health Plus Management, a physician support organization (PSO) providing business management and operations services for independent physician practices specializing in musculoskeletal care, today announced the appointment of Scott Asher as Chief Development Officer, and Claudia Hinrichsen, EsqFull story -
Optibrium introduces Augmented Chemistry™ services to guide successful drug discovery
Oct 10, 2019, 11:31 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Oct 10, 2019 - Optibrium, a developer of software for drug discovery, today announced the introduction of its Augmented Chemistry services, which provide collaborators with novel artificial intelligence technologies to supplement their skills and experience, enabling them to make more effective decisions and advance their drug discovery projectsFull story -
Scientists at the MDI Biological Laboratory Are Decoding the Genetic Mechanisms of Aging
Oct 10, 2019, 10:01 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Oct 10, 2019 - The discovery in the 1990s that a mutation in a single gene of an experimental worm could double its lifespan set off a stampede of research on the molecular biology of aging and triggered hopes that drug therapies or other interventions could be developed to extend healthy human lifespanFull story -
Irish Clinical Research Team Selects Shimmer’s Verisense Continuous Monitoring Platform to Study Breast Cancer-related Fatigue
Oct 10, 2019, 08:17 AM by Michael CroftCAMBRIDGE, MA - Oct 10, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that a team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) will be using Shimmers Verisense continuous monitoring platform to study fatigue accurately in individuals with breast cancerFull story -
MDI Biological Laboratory Scientist Receives Federal Grant to Study Aging
Oct 9, 2019, 19:42 PM by Michael CroftBAR HARBORE, ME, UNITED STATES - Oct 9, 2019 - BAR HARBOR, MAINE -- The MDI Biological Laboratory has announced that the U.S. Department of Health and Human Services has awarded a grant in the amount of $373,500 per year for five years to Aric Rogers, PhFull story -
Ontera Expands Executive Leadership Team as the Nanopore Diagnostics Company Advances Towards Product Commercialization
Oct 9, 2019, 12:57 PM by Michael CroftSANTA CRUZ, CA - Oct 9, 2019 - Ontera, the leader in silicon-based nanopore diagnostics, today announced the appointments of Mark Rose as vice president of product management and Raparti Swayambhu as vice president of softwareFull story -
Updated: Certara Launches BaseCase Data Studio, Enabling Pharma and MedTech Clients to Conduct Advanced Data Analyses During Value-based Product Discussions
Oct 9, 2019, 12:52 PM by Michael CroftPRINCETON, NJ - Oct 9, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Studio, the newest product for its BaseCase value communications platformFull story -
TraceLink Announces New Digital Network Platform to Further Transform the Global Pharmaceutical Supply Chain
Oct 9, 2019, 10:19 AM by Michael Croft- Oct 9, 2019 - TraceLink Inc., the worlds largest integrated digital supply network, announced the launch of the Digital Network Platform, today at its FutureLink event in NashvilleFull story -
Chromosome Connectors Take Center Stage for ORNL Scientists Studying Poplar
Oct 9, 2019, 09:43 AM by Michael CroftOAK RIDGE, TN - Oct 3, 2019 - The black cottonwood tree, or Populus trichocarpa (poplar), serves as a model organism for scientists studying the structure, growth, development, and genetics of plantsFull story -
How Do Acoustics Impact Data Center Efficiency?
Oct 9, 2019, 08:05 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Owners and managers are seeking intelligent solutions to address the unique risks of data centers and mission critical facilities. In any risk prevention plan, it is a priority to address risks related to access control and data security, however there are other hazards just as important but less obvious to consider: notably the risk of acoustics.
-
N-SIDE welcomes Wade Wirta as US Managing Director
Oct 9, 2019, 07:25 AM by Michael CroftLOUVAIN LA NEUVE, BELGIUM - Oct 9, 2019 - N-SIDE, a global software consulting company specializing in advanced analytics technologies, is pleased to welcome Wade Wirta as US Managing DirectorFull story -
New study demonstrates COMET technology for sperm DNA analysis improves diagnosis of male infertility and predicts success of IVF and ICSI
Oct 9, 2019, 07:24 AM by Michael CroftBELFAST, UK - Oct 9, 2019 - Examen, a world leader in male fertility testing, is pleased to announce the results of its latest study conducted in collaboration with the renowned Lister Fertility Clinic in LondonFull story -
Creative Diagnostics Introduces New Portfolio of Phospho-specific Antibodies
Oct 9, 2019, 02:51 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Oct 9, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics introduces extensive selection of newly developed phospho-specific antibodies for global scientists, which can be used in a variety of applications such as Western blot, immunoprecipitations, immunofluorescence, FACS, and ICCFull story -
Life Image and Graticule Announce Partnership to Help Biopharma Realize the Full Potential of Advanced Data in Real World Evidence Programs
Oct 8, 2019, 12:18 PM by Michael CroftNEWTON, MA - Oct 8, 2019 - Life Image, the worlds largest medical evidence network for clinical and imaging data, today announced a strategic partnership with Graticule, an advanced data firm that provides data subscriptions and advisory servicesFull story -
Ashfield appoints Business Development Director for Commercial and Patient Solutions in the UK
Oct 8, 2019, 06:44 AM by Michael Croft, UNITED KINGDOM - Oct 8, 2019 - Ashfield has today announced the appointment of Richard Clarke as Commercial and Patient Solutions Business Development DirectorFull story -
What Can Skin—and Sweat—Really Tell Us?
Oct 7, 2019, 11:25 AM by Michael CroftFull storyBio-IT World | What can the body's largest organ and its secretions teach us about human health? While the answer may be a bit unclear for now, scientists are pursuing wearable skin sensors that can monitor bodily signals of interest and glean useful information from perspiration.
-
NIH To Provide Grants For Advancing The Reference Sequence Of Human Genome
Oct 4, 2019, 09:40 AM by Michael CroftFull storyBio-IT World | The National Human Genome Research Institute will be providing grants totaling approximately $29.5 million to various universities and institutes in order to generate and maintain the most comprehensive reference sequence of the human genome.